Isis Pharmaceuticals, Inc. Requests that the marked portions of the exhibit be granted confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934.Letter Agreement Amendment • November 6th, 2012 • Isis Pharmaceuticals Inc • Pharmaceutical preparations
